Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
复制标题
Farnesoid X受体诱导的赖氨酸特异性组蛋白脱甲基酶降低肝胆酸水平,并保护肝脏免受胆汁酸毒性。
DOI:
10.1002/hep.27677
复制
发表时间:
2015-07
期刊:
影响因子:
13.5
通讯作者:
Kemper, Jongsook Kim
中科院分区:
文献类型:
--
作者:
Kim, Young-Chae;Fang, Sungsoon;Byun, Sangwon;Seok, Sunmi;Kemper, Byron;Kemper, Jongsook Kim
Bile acids (BAs) function as endocrine signaling molecules that activate multiple nuclear and membrane receptor signaling pathways to control fed-state metabolism. Since the detergent-like property of BAs causes liver damage at high concentrations, hepatic BA levels must be tightly regulated. BA homeostasis is regulated largely at the level of transcription by nuclear receptors, particularly the primary bile acid receptor, farnesoid X receptor (FXR), and small heterodimer partner (SHP) that inhibits BA synthesis by recruiting repressive histone-modifying enzymes. Although histone modifiers have been shown to regulate BA-responsive genes, their in vivo functions remain unclear. Here we show that lysine-specific histone demethylase1 (LSD1) is directly induced by BA-activated FXR, is recruited to BA synthetic genes, Cyp7a1 and Cyp8b1, and the BA uptake transporter gene, Ntcp, and removes a gene-activation mark, tri-methylated histone H3 lysine-4, leading to gene repression. LSD1 recruitment was dependent on SHP, and LSD1-mediated demethylation of H3K4-me3 was required for additional repressive histone modifications, H3K9/K14 deacetylation and H3K9 methylation. BA overload, feeding 0.5% cholic acid chow for 6 days, resulted in adaptive responses of altered expression of hepatic genes involved in BA synthesis, transport, and detoxification/conjugation. In contrast, adenoviral-mediated downregulation of hepatic LSD1 blunted these responses, which led to substantial increases in liver and serum BA levels, serum AST/ALT levels, and hepatic inflammation. This study identifies LSD1 as a novel histone-modifying enzyme in the orchestrated regulation mediated by the FXR and SHP that reduces hepatic BA levels and protects the liver against BA toxicity.
登录
查看更多内容
影响因子:
16
作者:
Mulligan P;Yang F;Di Stefano L;Ji JY;Ouyang J;Nishikawa JL;Toiber D;Kulkarni M;Wang Q;Najafi-Shoushtari SH;Mostoslavsky R;Gygi SP;Gill G;Dyson NJ;Näär AM
通讯作者:
Näär AM
影响因子:
25.7
作者:
Kosters, Astrid;Felix, Julio C.;Karpen, Saul J.
通讯作者:
Karpen, Saul J.
影响因子:
29.4
作者:
Modica, Salvatore;Petruzzelli, Michele;Moschetta, Antonio
通讯作者:
Moschetta, Antonio
影响因子:
13.5
作者:
Mitro, Nico;Godio, Cristina;Crestani, Maurizio
通讯作者:
Crestani, Maurizio
DOI:
10.1038/nrg2485
发表时间:
2009-01
期刊:
Nature reviews. Genetics
影响因子:
--
作者:
通讯作者:
--